Valuation: BPH GLOBNPV

Market Cap 3.53M 2.46M 2.17M 2.06M 1.86M 3.5M 236M 24.66M 9.51M 121M 9.25M 9.04M 388M P/E 2024
-0.35x
P/E 2025 -0.75x
Enterprise Value 3.38M 2.36M 2.08M 1.97M 1.78M 3.34M 226M 23.6M 9.09M 115M 8.85M 8.65M 371M EV / Sales 2024
11.9x
EV / Sales 2025 5.53x
Free-Float
69.73%
Yield 2024 *
-
Yield 2025 -
1 day+8.33%
Current month+30.00%
1 month+30.00%
3 months-13.33%
6 months-35.00%
Current year-35.00%
1 week 0.01
Extreme 0.012
0.01
1 month 0.01
Extreme 0.01
0.02
Current year 0.01
Extreme 0.01
0.03
1 year 0.01
Extreme 0.01
0.03
3 years 0.01
Extreme 0.01
0.1
5 years 0.01
Extreme 0.01
0.3
10 years 0.01
Extreme 0.01
54.25
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-20
Chief Tech/Sci/R&D Officer - 2026-05-24
Corporate Secretary - 2024-04-10
Director TitleAgeSince
Chairman - 2026-06-21
Director/Board Member 55 2023-03-29
Director/Board Member - 2025-04-21
Change 5-day change 1-year change 3-year change Capi.($)
+8.33%0.00%-35.00%-82.67% 2.15M
-0.03%+3.77%+12.35%+37.22% 49.06B
-0.73%-0.41%+48.84%+36.72% 44.6B
+1.36%+6.03%+343.85%+638.73% 43.24B
-0.47%-0.76%+9.75%+103.07% 41.73B
+0.34%+0.22%+5.18%+47.36% 29.93B
+1.00%-1.28%+24.23%+156.93% 17.19B
-2.94%+6.98%+5.10% - 15.35B
-3.20%-3.50%+25.33%+42.43% 15.54B
-0.86%-4.00% - - 15.11B
Average +0.28%+1.85%+48.85%+122.47% 27.18B
Weighted average by Cap. -0.28%+1.79%+74.43%+166.43%

Financials

2024 2025
Net sales 110K 76.7K 67.69K 64.04K 58.08K 109K 7.36M 768K 296K 3.76M 288K 282K 12.09M 352K 246K 217K 205K 186K 349K 23.58M 2.46M 949K 12.04M 923K 903K 38.76M
Net income -2.65M -1.85M -1.63M -1.54M -1.4M -2.63M -177M -18.53M -7.14M -90.63M -6.95M -6.79M -292M -1.49M -1.04M -915K -866K -785K -1.47M -99.49M -10.39M -4M -50.81M -3.89M -3.81M -163M
Net Debt 119K 83.35K 73.55K 69.59K 63.11K 118K 8M 835K 322K 4.08M 313K 306K 13.14M -153K -107K -94.02K -88.96K -80.68K -151K -10.22M -1.07M -411K -5.22M -400K -391K -16.8M
Logo BPH GLOBNPV
Ocean Sciences Ltd, formerly BPH Global Limited, is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company's product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.
Employees
31
Date Price Change Volume
26-09-29 A$0.0130 +8.33% 86,117
26-09-29 A$0.0120 -7.69% 177,618
26-09-25 A$0.0130 +8.33% 54,933
26-09-22 A$0.0120 0.00% 0